CATALOGO DEI PRODOTTI DELLA RICERCA

ADAMI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.950
NA - Nord America 1.910
AS - Asia 868
SA - Sud America 7
AF - Africa 5
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.746
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.901
CN - Cina 663
GB - Regno Unito 456
IT - Italia 269
RU - Federazione Russa 243
DE - Germania 223
SE - Svezia 223
IE - Irlanda 214
FR - Francia 190
SG - Singapore 108
FI - Finlandia 60
JP - Giappone 37
UA - Ucraina 20
KR - Corea 15
TR - Turchia 12
VN - Vietnam 12
NL - Olanda 11
AT - Austria 9
CA - Canada 9
BE - Belgio 7
HK - Hong Kong 6
PT - Portogallo 6
IR - Iran 5
IN - India 4
AU - Australia 3
BR - Brasile 3
CH - Svizzera 3
GR - Grecia 3
LV - Lettonia 3
ZA - Sudafrica 3
CZ - Repubblica Ceca 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
A1 - Anonimo 1
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
FK - Isole Falkland (Malvinas) 1
HR - Croazia 1
IQ - Iraq 1
KW - Kuwait 1
MA - Marocco 1
PE - Perù 1
PL - Polonia 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 4.746
Salva come PNG Salva come JPEG
Città #
Chandler 488
Southend 448
Dublin 209
Ashburn 171
Beijing 121
Jacksonville 100
Redmond 90
Wilmington 78
Lawrence 74
Princeton 74
Bologna 67
Singapore 66
Ann Arbor 61
New York 59
Jinan 58
Shenyang 53
Verona 48
Nanjing 46
Sindelfingen 46
Helsinki 43
Tokyo 36
Woodbridge 35
Hebei 34
Seattle 33
Tianjin 28
Washington 27
Zhengzhou 26
Taiyuan 22
Changsha 21
Haikou 21
Hangzhou 20
Ningbo 19
Houston 17
Nanchang 17
Dongguan 16
Fairfield 15
Guangzhou 15
Jiaxing 15
Redwood City 15
San Francisco 12
Taizhou 12
Norwalk 11
Seoul 11
Venice 11
Milan 10
Falls Church 8
Fuzhou 8
Miami 8
Vienna 8
Brussels 7
Dearborn 7
Hong Kong 6
Lanzhou 6
Los Angeles 6
Boydton 5
Chicago 5
Dong Ket 5
Düsseldorf 5
Kent 5
Rome 5
Amsterdam 4
Bari 4
Easton 4
Esslingen am Neckar 4
Falkenstein 4
Lappeenranta 4
Renton 4
Shanghai 4
Toronto 4
Biandronno 3
Cerea 3
Detroit 3
Faenza 3
Luino 3
Mehlingen 3
Nürnberg 3
São Paulo 3
Acquaviva Picena 2
Ardabil 2
Bergamo 2
Bratislava 2
Calais 2
Campobasso 2
Cascina 2
Chapel Hill 2
Chennai 2
Chiampo 2
Isola della Scala 2
Leawood 2
Lecce 2
Legnaro 2
London 2
Mesa 2
Minerbio 2
Moscow 2
Muizenberg 2
Northampton 2
Novokuznetsk 2
Offlaga 2
Ottawa 2
Totale 3.099
Salva come PNG Salva come JPEG
Nome #
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 145
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 118
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 113
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 110
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 105
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 101
Anti-CCP antibodies and bone 98
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 96
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 93
Safety issues and adverse reactions with osteoporosis management 91
Could γ\δ T-cells explain zoledronic acid adverse events? 91
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 89
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 85
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 83
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 83
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 82
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 82
Rheumatoid arthritis, γδ T cells and bisphosphonates 79
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 79
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 78
The obesity paradox and osteoporosis 74
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 69
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 68
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 66
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study 66
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 66
Association between environmental air pollution and rheumatoid arthritis flares 66
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 66
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 64
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 64
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 60
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) 60
Correction to: The obesity paradox and osteoporosis 59
Osteoporosis in Rheumatic Diseases 57
Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment 55
Gender disparity in authorship of guidelines and recommendations in rheumatology 54
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 50
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 50
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 49
Pharmacological treatment in adult patients with CRPS-I: A systematic review and meta-analysis of randomised controlled trials 49
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 48
Calcium and vitamin D supplementation: when and why 48
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 47
Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report 46
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 46
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 45
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis 44
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 44
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 44
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 44
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? 43
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 43
Acute Phase Reaction and Fracture Risk Reduction. Are Gamma‐Delta T Cells and hypovitaminosis D the Missing Link? 43
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 42
Comments on Kanis et al.: Algorithm for the management of patients at low, high, and very high risk of osteoporotic fractures 42
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 41
A Prospective Open‐Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study 41
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 40
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 40
Osteoporosis in 10 years time: a glimpse into the future of osteoporosis 40
Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3 39
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 35
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 35
The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes 34
Lack of Effect of Teriparatide on Joint Erosions in Rheumatoid Arthritis Is an Expected Result: Comment on the Article by Solomon et al 33
Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study 33
Temporal Trends and Factors Associated with Bisphosphonate Discontinuation and Restart 32
Efficacy of mud plus bath therapy as compared to bath therapy in osteoarthritis of hands and knees: a pilot single-blinded randomized controlled trial 31
A Prospective Open-Label Observational Study of a Buffered Soluble 70{\hspace{0.167em}}mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The {GastroPASS} Study 30
Glucocorticoid-induced osteoporosis: 2019 concise clinical review 29
New insights on the role, pathogenesis, and treatment of osteoporosis and bone erosions in rheumatoid arthritis 28
Glucocorticoid-induced osteoporosis update 26
Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes 26
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 25
Osteoporosis Pathophysiology, Epidemiology, and Screening in Rheumatoid Arthritis 25
Association between acute exposure to environmental air pollution and fragility hip fractures 24
Pragmatic Clinical Trials in Osteoporosis 24
Radiofrequency echographic multi spectrometry for the prediction of incident fragility fractures: A 5-year follow-up study 24
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 22
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 22
Cardiovascular Safety of Romosozumab: New Insights from Postmenopausal Women with Chronic Kidney Disease 21
Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency 19
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 19
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs) 18
Bone loss occurs in Inflammatory Rheumatic Musculoskeletal Diseases (iRMD) patients treated with low dose glucocorticoids, but is prevented by anti-osteoporosis medications 17
Radiofrequency echographic multi-spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis setting 16
Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome 16
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs) 15
Balancing benefits and risks in the era of biologics 15
Bone health status evaluation in men by means of REMS technology 14
Response to: ‘Correspondence on ‘Gender disparity in authorship of guidelines and recommendations in rheumatology’’ by Stewart et al 14
Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study 14
Regulation of bone mass in inflammatory diseases 13
Providing high-quality care remotely to patients with rare bone diseases during COVID-19 pandemic 13
Executive summary: Italian guidelines for diagnosis, risk stratification, and care continuity of fragility fractures 2021 12
Medication holidays in osteoporosis: evidence-based recommendations from the Italian guidelines on 'Diagnosis, risk stratification, and continuity of care of fragility fractures' based on a systematic literature review 11
Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life 10
Mining the pathogenesis of rheumatoid arthritis, the leading role of the environment 10
The line between COVID-19 pandemic and rare bone diseases 9
Vitamin D supplementation: much ado about nothing 9
Totale 4.846
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.577
article - articoli 21.577
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.154
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020346 0 8 7 58 39 50 37 6 36 24 28 53
2020/2021656 96 132 22 114 58 44 40 5 52 5 55 33
2021/2022579 59 129 8 20 30 21 15 34 56 20 27 160
2022/20231.499 88 151 118 286 127 345 15 68 170 36 74 21
2023/2024982 40 70 89 125 80 202 54 44 30 43 151 54
2024/2025195 111 84 0 0 0 0 0 0 0 0 0 0
Totale 4.950